Vikram Solar Q2FY27: consolidated PAT crashes 95% YoY to ₹5.9 Cr as margins compress
PAT -95.38% YoY · revenue -2.93% · margins compressing · miss vs street
₹1,077.42 Cr
-2.93% YoY
₹5.93 Cr
-95.38% YoY
0.54%
-10.9pp YoY
₹0.16
Vikram Solar's consolidated PAT for Q2FY27 (quarter ended September 30, 2026) collapsed 95.4% year-on-year to ₹5.9 Cr, down from ₹128.5 Cr in Q2FY26, even as consolidated revenue held roughly flat at ₹1,077.4 Cr (-2.9% YoY). The decline is also sequential: PAT fell 70% from Q1FY27's already-weak ₹19.8 Cr, while revenue dropped 31% from ₹1,563.1 Cr, undercutting Prabhudas Lilladher's pre-quarter estimate of roughly +35.6% YoY revenue growth (October 7, 2026 sector preview) by a wide margin — a clear miss against Street's growth expectation, not just a margin story.
Q2 FY-2027 vs prior quarters
The margin bridge explains most of the damage: consolidated operating margin (EBITDA/revenue) fell to 9.4% from 21.2% a year ago, even though it edged up from Q1's 8.1%, and net margin shrank to 0.5% from 11.4% YoY. Finance costs rose 35% YoY to ₹42.7 Cr and depreciation jumped 89% YoY to ₹65.8 Cr as the 9 GW TOPCon cell-plant capex lands on the balance sheet — consolidated borrowings have risen more than 6x since March 2026 to ₹631.8 Cr, and H1FY27 capex on property, plant and CWIP reached ₹981.6 Cr, consistent with management's cited ₹5,000 Cr FY27-28 capex plan. No exceptional items appear in either the standalone or consolidated statement this quarter, so the swing is operating, not a one-off.
The stock went into the print at ₹143.85, down 2% over the past month of trading.
What the summary numbers don't show
EPS (basic) ₹0.16 for the quarter vs ₹3.83 a year ago and ₹0.55 in Q1FY27.
FY27 EBITDA target of ₹1,500-1,600 Cr not reaffirmed; management deferred full-year guidance pending H1 clarity on DCR pricing, distribution penetration, and ALMM 2 policy finalization. Cell plant commissioning Q4 FY27 on track; 40-50% utilization targeted for FY28. Capex ~₹5,000 Cr in FY27-28.
— This quarter: missed
Management did not reaffirm the FY27 EBITDA target of ₹1,500-1,600 Cr flagged at the Q1 call; H1FY27 consolidated EBITDA of roughly ₹227 Cr tracks far below the run-rate that target implies, and no formal FY27 guidance is on record — consistent with the prior call's cautious tone and the deferral pending clarity on DCR pricing, distribution penetration and ALMM 2 policy. The one concrete positive on record is the 9 GW TOPCon cell plant, reported on track for December 2026 commissioning (October 23 project update), which management has tied to 40-50% utilisation in FY28. The quarter's order wins — a 289.87 MWp module order from NLC India (Oct 27) and a 187 MW supply order (Oct 15) — add to the book but aren't large enough to move this quarter's print. No management press release accompanied this filing, so there is no company commentary to reconcile against the numbers beyond the notes to the financial statements.
W1
9 GW TOPCon cell plant commissioning — on track for Dec 2026; ramp to management's targeted 40-50% utilisation in FY28 is the next margin lever to verify.
W2
FY27 EBITDA guidance (previously ₹1,500-1,600 Cr) remains undisclosed — watch for reinstatement once DCR pricing, distribution penetration and ALMM 2 policy finalise.
W3
Finance cost and depreciation trajectory as the ~₹5,000 Cr FY27-28 capex plan continues; H1FY27 capex already ₹981.6 Cr (consolidated).
Figures converted from ₹ million (source) to ₹ Cr; no exceptional items in either statement this quarter; ₹148.5 Cr safeguard-duty receivable (sub judice) and ₹52.8 Cr withheld trade receivables are balance-sheet contingencies per Notes 6-7, not P&L items; EPS not annualised for the quarter.
Informational and educational content only. Not investment advice.